REQUEST A DEMO
Total
USD $0.00
Search more companies

Ibnsina Pharma S.A.E. (Egypt)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Ibnsina Pharma S.A.E. Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Ibnsina Pharma is an Egyptian company that started operations in 2001 as a pharmaceutical distribution company under the name Ibnsina Laborex Pharma. Initially, the company was a collaboration between local businessperson Mohamed Abd El Gawad and French Europharma Group, but in 2006 the Egyptian party managed to buy out all French shares and changed the company's name to the present Ibnsina Pharma. Since then, the company's management has pursued aggressive growth strategy, expanding its market share to 13.5% in 2015. Currently, Ibnsina Pharma supplies pharmaceuticals and cosmetic products to more than 30,000 customers including retailers and independent pharmacy chains added to wholesalers and institutional providers. The company cooperates with 360 public, private and multinational pharmaceutical production companies in Egypt.

Headquarters
Bulding No. 234, 2Nd District, 5Th Settlement, New Cairo
Cairo; Greater Cairo;

Contact Details: Purchase the Ibnsina Pharma S.A.E. report to view the information.

Website: http://www.ibnsina-pharma.com

Basic Information
Total Employees:
Purchase the Ibnsina Pharma S.A.E. report to view the information.
Outstanding Shares:
Purchase the Ibnsina Pharma S.A.E. report to view the information.
Financial Auditors:
Purchase the Ibnsina Pharma S.A.E. report to view the information.
Incorporation Date:
2001
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Ownership Details
Purchase this report to view the information.
5%
Subsidiaries
A.I.M For Investing And Medical Consulting
Dg Three Sixty For Programming
Ramb For Logistics Services Company
Company Performance
Financial values in the chart are available after Ibnsina Pharma S.A.E. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EGP. Absolute financial data is included in the purchased report.
Net sales revenue
50.56%
Total operating revenue
50.55%
Operating profit (EBIT)
124.91%
EBITDA
93.19%
Net Profit (Loss) for the Period
46.66%
Total assets
51.19%
Total equity
13.12%
Operating Profit Margin (ROS)
1.27%
Net Profit Margin
-0.02%
Return on Equity (ROE)
2.82%
Debt to Equity Ratio
472.39%
Quick Ratio
-0.01%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?